A quarterly cash dividend of $18.75 per share was declared on its 7.50% noncumulative perpetual convertible class A preferred stock, Series L, liquidation preference $1,000 per share, which is traded on the New York Stock Exchange under the symbol WFCPrL
- GHK-Cu is a copper-binding peptide studied in advanced research models involving cellular signaling, tissue remodeling, collagen-related pathways, oxidative stress, and skin/hair-focused research applications
Patient-derived glial enriched progenitors repair functional deficits due to white matter stroke and vascular dementia in rodents
Oxidative stress occurring in skin cells can lead to diseases including not just psoriasis, but eczema and some skin cancers as well
Injecting a larger dose will result in a higher peak concentration, but the rate of decaythe GHK-Cu half liferemains the same
Supplementation prevents these sequelae in patients whose dietary intake is restricted